Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
662-02-014 ISMRM Abstract

Pretreatment Amide Proton Transfer Imaging for Predicting the Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma

Primary: Acquisition & Reconstruction - Quantitative Imaging: head and neck
Secondary: Body - Body Composition
662-02-014 · Advances in Chemical Exchange MRI: CEST, APT, and NOE II · Thursday, 14 May, 9:25 AM–10:20 AM · Digital Posters Row C
Keywords: Radiomics Nasopharyngeal carcinoma Induction chemotherapy APT
Accepted
Zheng Zeng 1, Liyan Zou1, wei cui2,3,4, Zhou Liu1,1,5,6, Dehong Luo1,6
1National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
2MRI Research, GE Healthcare, Beijing, China
3GE HealthCare MR Research, Beijing, China
4MRI Research, GE Healthcare, Beijing, China
5Department of Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, shenzhen, China
6Department of Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Presenting Author: Zheng Zeng

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Liu SL, Sun XS, Yan JJ, et al. Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response. Radiother Oncol. 2019;137:83-94. doi:10.1016/j.radonc.2019.04.020 [doi]
2. Wang HJ, Cai Q, Huang YP, et al. Amide Proton Transfer-weighted MRI in Predicting Histologic Grade of Bladder Cancer. Radiology. 2022;305(1):127-134. doi:10.1148/radiol.211804 [doi]
3. Choi SH. Can Amide Proton Transfer MRI Distinguish Benign and Malignant Head and Neck Tumors?. Radiology. 2018;288(3):791-792. doi:10.1148/radiol.2018180914 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/662-02-014